Bio-Path Holdings Files 8-K
Ticker: BPTH · Form: 8-K · Filed: Apr 15, 2024 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, financials
Related Tickers: BPTH
TL;DR
BPTH filed an 8-K, likely covering financials and other events. No major news yet.
AI Summary
Bio-Path Holdings, Inc. filed an 8-K on April 15, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events or financial figures, but rather serves as a notification of these categories being addressed.
Why It Matters
This filing indicates that Bio-Path Holdings, Inc. is updating or providing information related to its financial statements and other significant events, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new material information that would immediately impact the company's risk profile.
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Registrant
- April 15, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-36333 (identifier) — Commission File Number
- 87-0652870 (identifier) — IRS Employer Identification No.
- 4710 Bellaire Boulevard , Suite 210 , Bellaire , Texas 77401 (address) — Address of principal executive offices
FAQ
What specific "Other Events" are being reported by Bio-Path Holdings, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events'; it only lists the category.
What "Financial Statements and Exhibits" are included or referenced in this 8-K filing?
The filing indicates that 'Financial Statements and Exhibits' are part of the report, but the specific content or details of these statements and exhibits are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 15, 2024, as indicated by the 'Date of earliest event reported'.
What is the principal executive office address for Bio-Path Holdings, Inc.?
The principal executive office address for Bio-Path Holdings, Inc. is 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401.
Has Bio-Path Holdings, Inc. had previous names or former companies associated with it?
Yes, Bio-Path Holdings, Inc. was formerly known as BIO-PATH HOLDINGS INC (name change on 20080221) and prior to that, OGDEN GOLF CO CORP (name change on 20010205).
Filing Stats: 426 words · 2 min read · ~1 pages · Grade level 10.4 · Accepted 2024-04-15 07:30:12
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M
Filing Documents
- bpth-20240415x8k.htm (8-K) — 38KB
- bpth-20240415xex99d1.htm (EX-99.1) — 17KB
- bpth-20240415xex99d1001.jpg (GRAPHIC) — 11KB
- 0001558370-24-005060.txt ( ) — 192KB
- bpth-20240415.xsd (EX-101.SCH) — 3KB
- bpth-20240415_lab.xml (EX-101.LAB) — 16KB
- bpth-20240415_pre.xml (EX-101.PRE) — 10KB
- bpth-20240415x8k_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On April 15, 2024, Bio-Path Holdings, Inc. (the "Company") issued a press release titled, "Bio-Path Holdings Expands Global Patent Portfolio." A copy of such press release is attached hereto as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press release dated April 15, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: April 15, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer